Current Issue
From Aberrant Results to Alternative Methods: Strengthening Pharmaceutical Laboratory Deci...
Dr Markus Funk, Operations Director Analytics Axel. H. Schroeder, Operations Director Micr...
Sterility Assurance – An Enabler to Comply with Annex 1
Robert Dream, Managing Director, HDR Company LLC
Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...
Bonnie K. Shum, Senior Director, Product Technical Leader, Genentech
Raw Material Qualification – A Practical Approach
Aurora Henry, GMP Quality/ Raw Material Quality/Material Control Leader
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
JSR Life Sciences
Featured Articles
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
Bringing the Freezing of Biopharmaceuticals in From the Cold
View All Featured ArticlesHeadline News
FDA approves Klygefa for adults with generalised myasthenia gravis
Johnson & Johnson to acquire Ollin Biosciences for $2.2bn to expand ophthalmology pipeline
Andelyn partners with Celliaz to manufacture AAV gene therapy for retinitis pigmentosa
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
BPOG Risk Based Approaches to Use of Closed Systems in Renovations of Existing Biopharma API Facilities
Presented by Lars Hovmand-Lyster, Senior Engineering specialist in Novo Nordisk Global Project Office (GPO) Engineering management department and Ernest Jenness, Senior Product Manager for Mobius Single-Use Products at Merck
05th March 2019
Advances in the Purification of Antisense Oligonucleotides
Presented by Robert Gronke, Ph.D., Senior Principal Scientist, Technical Development, Biogen and John Cyganowski, Director of Customer Application, Downstream, Merck
27th October 2021
Developing Practical Single-Use Processes for New Vaccine Formulations
Presented by Kirsten Strahlendorf of Sanofi Pasteur
16th May 2017
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere TM A3
Strategy Emerging Markets for Risk Mitigation
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















